Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. scores highest on Torque (45) and lowest on Nitro (11). Its PosiPenta is 31.25 out of 100, weaker than most similar companies.
On the Penta Grid this week, Intensity Therapeutics, Inc. is Grid #739 of 837 in the Healthcare sector in United States, and Grid #3,543 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Intensity Therapeutics, Inc. | 31.25 | 37 | 37 | 11 | 45 | 26 |
| Lisata Therapeutics, Inc. | 40.49 | 35 | 40 | 19 | 58 | 50 |
| Caring Brands, Inc. | 41.34 | 0 | 54 | 68 | 38 | 47 |
| DataMEDS AI, Inc. | 33.03 | 0 | 2 | 15 | 97 | 51 |
| Cellectar Biosciences, Inc. | 36.66 | 47 | 37 | 16 | 41 | 42 |
| Kiora Pharmaceuticals, Inc. | 47.63 | 44 | 28 | 79 | 57 | 30 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.86 |
| P/B ratio | 1.19 |
EEarnings
| Trailing EPS | ₹-368.44 |
| Forward EPS | ₹-188.80 |
NNitro
| Price | 317.30 |
| 52-week high | 4120.10 |
| 52-week low | 293.33 |
| Fall from 52-week high | 92.3% |
TTorque
| Return on equity (ROE) | -195.88% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 3.08 |
| Market cap | ₹103 Cr |
| Insider holding | 3.92% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Intensity Therapeutics, Inc.'s PosiPenta score?
Intensity Therapeutics, Inc.'s PosiPenta is 31.25 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Intensity Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Intensity Therapeutics, Inc. is Grid #739 of 837 in the Healthcare sector in United States, and Grid #3,543 of 4,000 in United States.
Which PosiPenta pillar is strongest for Intensity Therapeutics, Inc.?
Torque (durability), with a score of 45 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Intensity Therapeutics, Inc.?
Nitro (momentum), with a score of 11 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.